The temporal-spatial expression of VEGF, angiopoietins-1 and 2, and Tie-2 during tumor angiogenesis and their functional correlation with tumor neovascular architecture

Neurological Research

Volumn 25, Issue 7, 2003, Pages 729-738

  Tse, Victor ^a,b   Xu, Lei ^a   Yung, Yun C ^a   Santarelli, Justin G ^a   Juan, David ^a   Fabel, Klaus ^a   Silverberg, Gerald ^a   Harsh IV, Griffith ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

Author keywords

Angiopoietin 1; Angiopoietin 2; Glioblastoma; Tie 2; Tumor vasculature; VEGF

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENETIC TRANSCRIPTION; GLIOBLASTOMA; NONHUMAN; PROTEIN EXPRESSION; RAT; TUMOR VASCULARIZATION; VASCULAR FRAGILITY;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, INBRED F344; RECEPTOR, TIE-2; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0142058307     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164103101202084     Document Type: Article

References (37)

1. Scherer H. Gliomstudien III Angioplasticche Glioma. Virchow Arch 1935; 294: 823-826
2. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award lecture. Cancer Res 1986; 46: 467-473
3. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999; 284: 1994-1998
4. Plate KH, Mennel HD. Vascular morphology and angiogenesis in glial tumors. Exp Toxicol Pathol 1995; 47: 89-94
5. Plate KH, Breier G, Risau W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 1994; 4: 207-218
6. Folkman J, D'Amore PA. Blood vessel formation: What is its molecular basis? Cell 1996; 87: 1153-1155
7. Mochizuki Y, Nakamura T, Kanetake H, Kanda S. Angiopoietin 2 stimulates migration and tube-like structure formation of murine brain capillary endothelial cells through c-Fes and c-Fyn. J Cell Sci 2002; 115: 175-183
8. Stratmann A, Risati W, Plate KH. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 1998; 153: 1459-1466
9. Zagzag D, Friedlander DR, Margolis B, Grumet M, Semenza GL, Zhong H, et al. Molecular events implicated in brain tumor angiogenesis and invasion. Pediatr Neurosurg 2000; 33: 49-55
10. Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, et al. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest 2002; 109: 777-785
11. Yu Q, Stamenkovic I. Angiopoietin-2 is implicated in the regulation of tumor angiogenesis. Am J Pathol 2001; 158: 563-570
12. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 1998; 8: 529-532
13. Tian S, Hayes AJ, Metheny-Barlow LJ, Li LY. Stabilization of breast cancer xenograft tumour neovasculature by angiopoietin-1. Br J Cancer 2002; 86: 645-651
14. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000; 6: 460-463
15. Audero E, Cascone I, Zanon I, Previtali SC, Piva R, Schiffer D, et al. Expression of angiopoietin-1 in human glioblastomas regulates tumor-induced angiogenesis: In vivo and in vitro studies. Arterioscler Thromb Vasc Biol 2001; 21: 536-541
16. Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. Circ Res 2000; 86: 24-29
17. Hanahan D. Signaling vascular morphogenesis and maintenance. Science 1997; 277: 48-50
18. Hswiao M, Tse V, Carmel J, Tsai Y, Felgner PL, Haas M, et al. Intracavitary liposome-mediated p53 gene transfer into glioblastoma with endogenous wild-type p53 in vivo results in tumor suppression and long-term survival. Biochem Biophys Res Commun 1997; 233: 359-364
19. Mandriota SJ, Pepper MS. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 1998; 83: 852-859
20. Lindgren M, Johansson M, Sandstrom J, Jonsson Y, Bergenheim AT, Henriksson R. VEGF and tPA co-expressed in malignant glioma. Acta Oncol 1997; 36: 615-618
21. Lin TN, Wang CK, Cheung WM, Hsu CY. Induction of angiopoietin and Tie receptor mRNA expression after cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 2000; 20: 387-395
22. Wesseling P, van der Laak JA, de Leeuw H, Ruiter DJ, Burger PC. Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections. J Neurosurg 1994; 81: 902-909
23. Scherer H. Cerebral astrocytomas and their derivatives. Am J Cancer 1940; 40: 158-198
24. Lauren J, Gunji Y, Alitalo K. Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? Am J Pathol 1998; 153: 1333-1339
25. Hansbury MJ, Nicosia RF, Zhu WH, Holmes SJ, Winkler JD. Production and characterization of a Tie2 agonist monoclonal antibody. Angiogenesis 2001; 4: 29-36
26. Holash J, Wiegand SJ, Yancopoulos GD. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 1999; 18: 5356-5362
27. Plate KH, Breier G, Welch HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992; 359: 845-848
28. Song HS, Son MJ, Lee YM, Kim WJ, Lee SW, Kim CW, et al. Oxygen tension regulates the maturation of the blood-brain barrier. Biochem Biophys Res Commun 2002; 290: 325-331
29. Ikeda E, Achen MG, Breier G, Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 1995; 270: 19761-19766
30. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845
31. Abdulmalek K, Ashur F, Ezer N, Ye F, Magder S, Hussain SN. Differential expression of Tie-2 receptors and angiopoietins in response to in vivo hypoxia in rats. Am J Physiol Lung Cell Mol Physiol 2001; 281: L582-L590
32. Koblizek TI, Runting AS, Stacker SA, Wilks AF, Risau W, Deutsch U. Tie2 receptor expression and phosphorylation in cultured cells and mouse tissues. Eur J Biochem 1997; 244: 774-779
33. Huang L, Turck CW, Rao P, Peters KG. GRB2 and SH-PTP2: Potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase. Oncogene 1995; 11: 2097-2103
34. Chang YS, di Tomaso E, McDonald DM, Jones R, Jain RK, Munn LL. Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci USA 2000; 97: 14608-14613
35. Mandriota SJ, Pyke C, Di Sanza C, Quinodoz P, Pittet B, Pepper MS. Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia. Am J Pathol 2000; 156: 2077-2089
36. Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGFR-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA 2002; 99: 11205-11210
37. Peoch M, Farion R, Hiou A, Le Bas JF, Pasquier B, Remy C. Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain. Anticancer Res 2002; 22: 2147-2151